Journal article · 2026

TREM2: friend or foe in glioma?

Mekenzie Peshoff, Dolores Hambardzumyan, Long‐Jun Wu

Brain · Published 25 October 2026 · DOI 10.1093/brain/awag369

View at the publisherCite this paper

In brief

“TREM2: friend or foe in glioma?” is a 2026 journal article by Mekenzie Peshoff and 2 co-authors, published in Brain. OpenAlex counts 1 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.87
Authors
3

Abstract

Triggering receptor expressed on myeloid cells 2 (TREM2) is a neuroimmune signaling hub involved in key cellular processes including microglial phagocytosis, chemotaxis, and inflammation. Dysregulation of TREM2 has been implicated in a variety of diseases, most notably in the innate immune response to neurodegenerative disorders and cancer. The TREM2 pathway plays a significant role in… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Peshoff, M., Hambardzumyan, D., & Wu, L. (2026). TREM2: friend or foe in glioma? Brain. https://doi.org/10.1093/brain/awag369

MLA 9

Peshoff, Mekenzie, et al. “TREM2: friend or foe in glioma?” Brain, 2026. https://doi.org/10.1093/brain/awag369.

Chicago

Peshoff, Mekenzie, Dolores Hambardzumyan, and Long‐Jun Wu. 2026. “TREM2: friend or foe in glioma?” Brain. https://doi.org/10.1093/brain/awag369.

Harvard

Peshoff, M., Hambardzumyan, D. and Wu, L. (2026) ‘TREM2: friend or foe in glioma?’, Brain. doi:10.1093/brain/awag369.

IEEE

M. Peshoff, D. Hambardzumyan, and L. Wu, “TREM2: friend or foe in glioma?,” Brain, 2026, doi: 10.1093/brain/awag369.

BibTeX

@article{peshoff2026trem,
  title     = {{TREM2: friend or foe in glioma?}},
  author    = {Peshoff, Mekenzie and Hambardzumyan, Dolores and Wu, Long‐Jun},
  journal   = {Brain},
  year      = {2026},
  doi       = {10.1093/brain/awag369},
  url       = {https://doi.org/10.1093/brain/awag369}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms

  • TREM2
  • glioma
  • microglia
  • neuroimmune signaling
  • tumor-associated macrophages
  • myeloid cells
  • neuroinflammation
  • brain tumors

Work with this paper

Most-cited papers in Neuroscience

All highly cited Neuroscience papers

Questions about this paper

How do I cite this paper in APA style?

Peshoff, M., Hambardzumyan, D., & Wu, L. (2026). TREM2: friend or foe in glioma? Brain. https://doi.org/10.1093/brain/awag369

How many times has this paper been cited?

1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Mekenzie Peshoff, Dolores Hambardzumyan, Long‐Jun Wu.

What is the DOI of this paper?

10.1093/brain/awag369, permanently at https://doi.org/10.1093/brain/awag369. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.